Cas:226916-19-4 3-(1,4-dioxaspiro[4.5]dec-7-en-7-yl)prop-2-enoic acid manufacturer & supplier

We serve Chemical Name:3-(1,4-dioxaspiro[4.5]dec-7-en-7-yl)prop-2-enoic acid CAS:226916-19-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-(1,4-dioxaspiro[4.5]dec-7-en-7-yl)prop-2-enoic acid

Chemical Name:3-(1,4-dioxaspiro[4.5]dec-7-en-7-yl)prop-2-enoic acid
CAS.NO:226916-19-4
Synonyms:3-(1,4-dioxaspiro[4.5]dec-7-en-7-yl)prop-2-enoic acid
Molecular Formula:C11H14O4
Molecular Weight:210.22600
HS Code:2932999099

Physical and Chemical Properties:
Melting point:N/A
Boiling point:406.7ºC at 760 mmHg
Density:1.25g/cm3
Index of Refraction:1.555
PSA:55.76000
Exact Mass:210.08900
LogP:1.48060

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-(1,4-dioxaspiro[4.5]dec-7-en-7-yl)prop-2-enoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(1,4-dioxaspiro[4.5]dec-7-en-7-yl)prop-2-enoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(1,4-dioxaspiro[4.5]dec-7-en-7-yl)prop-2-enoic acid Use and application,3-(1,4-dioxaspiro[4.5]dec-7-en-7-yl)prop-2-enoic acid technical grade,usp/ep/jp grade.


Related News: The Lonza team also contains regulatory specialists with experience working with Chinese regulators throughout the drug development and scale-up process. Approximately 250 employees work at Lonza’s Nansha site; this expansion is expected to create around 70 new positions. 2-Thiopheneacetamide, N-[3-(1H-benzimidazol-2-yl)-4-chlorophenyl]- manufacturers CDMOs closely work with companies who want to pursue upcoming innovations in medicines, help cope with shortcomings of internal lab-to-manufacturing scale-up. ethyl 3-[2-[2-(2-naphthyl)ethoxy]-4-(1H-pyrazol-1-ylmethyl)phenyl]propanoate suppliers Mindset Pharma Inc. is a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet needs. bromodi(tert-butyl)phosphane vendor & factory.